Compare EHTH & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | PRPO |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 40.1M |
| IPO Year | 2006 | 2000 |
| Metric | EHTH | PRPO |
|---|---|---|
| Price | $1.32 | $21.85 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 280.0K | 89.4K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 71.43 | ★ 92.15 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,395,000.00 | $24,049,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.60 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 45.86 | 29.77 |
| 52 Week Low | $1.20 | $13.80 |
| 52 Week High | $5.89 | $33.63 |
| Indicator | EHTH | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 35.36 | 43.78 |
| Support Level | $1.21 | $22.36 |
| Resistance Level | $1.58 | $25.98 |
| Average True Range (ATR) | 0.07 | 1.90 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 1.30 | 5.40 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.